Range Low Price High Price Comment
30 days $14.59 $16.25 Monday, 29th Apr 2024 CPRX stock ended at $15.23. This is 2.28% more than the trading day before Friday, 26th Apr 2024. During the day the stock fluctuated 2.07% from a day low at $14.98 to a day high of $15.29.
90 days $13.12 $17.50
52 weeks $11.09 $17.77

Historical Catalyst Pharmaceuticals prices

Date Open High Low Close Volume
May 01, 2023 $15.94 $16.96 $15.91 $16.94 1 590 927
Apr 28, 2023 $15.68 $15.94 $15.55 $15.92 1 121 663
Apr 27, 2023 $16.02 $16.02 $15.54 $15.76 1 373 506
Apr 26, 2023 $16.13 $16.42 $15.91 $16.02 977 832
Apr 25, 2023 $16.27 $16.48 $15.93 $16.09 1 289 559
Apr 24, 2023 $16.41 $16.59 $15.97 $16.52 1 228 567
Apr 21, 2023 $16.40 $16.49 $16.14 $16.48 1 520 092
Apr 20, 2023 $17.20 $17.33 $16.45 $16.50 2 497 845
Apr 19, 2023 $17.74 $17.78 $17.26 $17.33 1 872 764
Apr 18, 2023 $18.17 $18.22 $17.69 $17.82 1 506 890
Apr 17, 2023 $17.75 $18.19 $17.68 $18.08 1 892 019
Apr 14, 2023 $17.95 $18.07 $17.46 $17.69 1 471 838
Apr 13, 2023 $17.71 $18.11 $17.66 $17.97 2 010 808
Apr 12, 2023 $17.66 $17.88 $17.50 $17.55 1 504 681
Apr 11, 2023 $17.35 $17.72 $17.35 $17.55 2 189 941
Apr 10, 2023 $17.30 $17.42 $16.78 $17.26 2 217 334
Apr 06, 2023 $16.94 $17.41 $16.83 $17.38 1 939 329
Apr 05, 2023 $16.71 $17.10 $16.62 $16.93 1 164 523
Apr 04, 2023 $16.77 $16.86 $16.32 $16.78 1 493 412
Apr 03, 2023 $16.73 $17.27 $16.59 $16.94 1 478 626
Mar 31, 2023 $16.54 $16.74 $16.42 $16.58 2 182 837
Mar 30, 2023 $16.76 $16.84 $16.23 $16.46 1 154 738
Mar 29, 2023 $16.49 $16.86 $16.45 $16.72 1 428 024
Mar 28, 2023 $16.63 $16.99 $16.22 $16.37 1 553 323
Mar 27, 2023 $16.22 $16.53 $16.07 $16.44 1 180 597
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT